On January 10, 2025, China’s State Administration for Market Regulation (“SAMR”) put into effect its Compliance Guidelines for Healthcare Companies to Prevent Commercial Bribery Risks (“Compliance Guidelines”)....more
2/12/2025
/ Anti-Corruption ,
China ,
Clinical Laboratories ,
Compliance ,
Corporate Governance ,
Corruption ,
Enforcement Actions ,
Fraud ,
Health Care Providers ,
Healthcare ,
Healthcare Fraud ,
Medical Research ,
Pharmaceutical Industry ,
Regulatory Agenda ,
Regulatory Requirements ,
Risk Management
Designed for busy in-house counsel, compliance professionals, and anti-corruption lawyers, this newsletter summarizes some of the most important international anti-corruption law and enforcement developments from the past...more
11/13/2024
/ Anti-Corruption ,
Arms Export Control Act ,
Brazil ,
Bribery ,
Corporate Counsel ,
Defense Contracts ,
Deferred Prosecution Agreements ,
Department of Justice (DOJ) ,
Foreign Corrupt Practices Act (FCPA) ,
India ,
ITAR ,
OECD ,
Oil & Gas ,
Popular ,
Securities and Exchange Commission (SEC) ,
UK ,
United Nations ,
Venezuela